“Safety And Efficacy Of A Novel Vaginal Anti-Infective, Tol-463, In The Treatment Of Bacterial Vaginosis And Vulvovaginal Candidiasis: A Randomized, Single-Blind, Phase 2, Controlled Trial.”. Clin Infect Dis 68 (5). Clin Infect Dis: 803-809. doi:10.1093/cid/ciy554.
. 2019.